Nuvan Rathnayaka

Nuvan Rathnayaka

Auto-generated profile, based on publicly available information

Nuvan Rathnayaka

Headwater Science , Durham, North Carolina

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
FMF. Gerard Moeller
F. Gerard Moeller
JSJoel L. Steinberg
Joel L. Steinberg
JSJoy M. Schmitz
Joy M. Schmitz
LMLiangsuo Ma
Liangsuo Ma
SLShijing Liu
Shijing Liu
PNPonnada A. Narayana
Ponnada A. Narayana

1 March 2014 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
JSJoy M. Schmitz
Joy M. Schmitz
CGCharles E. Green
Charles E. Green
ASAngela L. Stotts
Angela L. Stotts
JLJan A. Lindsay
Jan A. Lindsay
NRNuvan S. Rathnayaka
Nuvan S. Rathnayaka
FMF. Gerard Moeller
F. Gerard Moeller

1 January 2012 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
JSJoy M. Schmitz
Joy M. Schmitz
NRNuvan Rathnayaka
Nuvan Rathnayaka
CGCharles E. Green
Charles E. Green
FMF. Gerard Moeller
F. Gerard Moeller
ADAnne E. Dougherty
Anne E. Dougherty
JGJohn Grabowski
John Grabowski
Background: Two stimulant medications, modafinil and d-amphetamine, when tested individually, have shown safety and efficacy for treatment of cocaine addiction. We hypothesized that the combination of modafinil and d-amphetamine, at low doses, would show equivalent or greater benefit in reducing cocaine use compared to higher doses of each individual medication or placebo. Methods: Sixteen week, randomized, parallel-group design with four treatment arms comparing placebo to modafinil 400 mg; d-amphetamine 60 mg; modafinil 200 mg plus d-amphetamine 30 mg. Primary outcome variables, retention and cocaine use, were analyzed on the sample of 73 participants who received the first dose of the study medication. Results: Retention rates did not differ between groups and were generally low, with 40% remaining in treatment at week 12 and 20% at week 16. Participants receiving the combination of modafinil and d-amphetamine showed a trend of increased cocaine use over time with a corresponding low Bayesian probability of benefit (33%). Relatively better cocaine outcomes were observed in the placebo and d-amphetamine only groups. The study medications were generally well-tolerated with few adverse effects, yet rates of adherence were suboptimal (≤80%). Conclusion: Data from this preliminary investigation fail to provide evidential support for conducting a larger study of this dual-agonist medication combination for treatment of cocaine dependence.

12 March 2014 in Behavioral Medicine
Verified
Journal Article
Closed access
JSJyoti Sharma
Jyoti Sharma
NRNuvan Rathnayaka
Nuvan Rathnayaka
CGCharles Green
Charles Green
FMF. Gerard Moeller
F. Gerard Moeller
JSJoy M. Schmitz
Joy M. Schmitz
ADAnne Hamilton Dougherty
Anne Hamilton Dougherty
Few studies have examined the effects of chronic cocaine use on the resting surface electrocardiogram (ECG) between exposures to cocaine. Researchers compared 12-lead ECGs from 97 treatment-seeking cocaine-dependent patients, with ECG parameters from 8,513 non-cocaine-using control patients from the Atherosclerosis Risk in Communities study. After matching and adjusting for relevant covariates, cocaine use demonstrated large and statistically reliable effects on early repolarization, bradycardia, severe bradycardia, and heart rate. Current cocaine dependence corresponds to an increased odds of demonstrating early repolarization by a factor of 4.92 and increased odds of bradycardia and severe bradycardia by factors 3.02 and 5.11, respectively. This study demonstrates the novel finding that long-lasting effects of cocaine use on both the cardiac conduction and the autonomic nervous system pose a risk of adverse cardiovascular events between episodes of cocaine use, and that bradycardia is a marker of chronic cocaine use.

1 June 2015 in Addictive Disorders & Their Treatment
Verified
Journal Article
Closed access
NDNadeeka R. Bsc Dias
Nadeeka R. Bsc Dias
SLScott D. Lane
Scott D. Lane
NRNuvan Ba Rathnayaka
Nuvan Ba Rathnayaka
JSJoy M. Schmitz
Joy M. Schmitz
CGCharles E. Green
Charles E. Green
Objectives: Underlying heterogeneity among individuals with cocaine dependence is widely postulated in the literature; however, identification of a group of factors that explain risk of cocaine use severity has yet to be confirmed. Methods: Latent mixture modeling evaluated 338 cocaine-dependent individuals recruited from the community to assess the evidence for the presence of distinct subgroups. Variables included 5 baseline questionnaires measuring cognitive function (Shipley), impulsivity (BIS), mood (BDI), affective lability (ALS), and addiction severity (ASI). Results failed to suggest multiple subgroups. Given a lack of evidence for discrete latent classes, an exploratory factor analysis followed by exploratory structural equation modeling was implemented to identify functional dimensions to enhance interpretation of these variables. Results: Findings from the exploratory factor analysis indicated a 3-factor model as the best fit, and the subsequent exploratory structural equation modeling solution resulted in associations with lifetime cocaine use. Factor 1, best characterized by demographic factors (sex and age), is associated with less lifetime cocaine use. Psychological problems best characterize factor 2, which is associated with higher lifetime cocaine use. Finally, factor 3 is characterized by other substance use (alcohol and marijuana). Although this factor did not demonstrate a statistically reliable relation with self-reported, lifetime cocaine use, it did indicate a potentially meaningful positive association. Conclusions: These 3 factors delineate dimensions of functioning that likewise help characterize the variability found in previously established associations with self-reported cocaine use.

1 January 2017 in Clinical Research and Trials
Verified
Journal Article
Open access
NRNuvan S. Rathnayaka
Nuvan S. Rathnayaka
JVJessica Vincent
Jessica Vincent
FMF. Gerard Moeller
F. Gerard Moeller
JSJoy M. Schmitz
Joy M. Schmitz
CGCharles E. Green
Charles E. Green